ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,851, issued on Nov. 25, was assigned to Incyte Corp. (Wilmington, Del.).
"Process and intermediates for preparing a JAK inhibitor" was invented by Jiacheng Zhou (Newark, Del.), Pingli Liu (Wilmington, Del.), James M. Parks (Newark, Del.), Naijing Su (Hockessin, Del.) and Weiguo Liu (Wilmington, Del.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to processes for preparing ruxolitinib, or a salt thereof, and related synthetic intermediates related thereto."
The patent was filed on Dec. 15, 2023, under Application No. 18/541,579.
*For further information, including images, charts and tables, please visit: http://patf...